Several U.S. Food and Drug Administration (FDA) employees, including some involved in reviewing Elon Musk’s Neuralink, have been fired or released recently. Now, the FDA wants them back.
Elon Musk's Neuralink celebrates the anniversary of its first human implant as it moves toward the beginning of its brain-chip trials expanding to Miami.
Neuralink, Elon Musk’s brain-computer interface (BCI) company, has received the FDA's “breakthrough device” designation for its innovative 'Blindsight' implant.
Neuralink has implanted its experimental N1 brain-computer interface (BCI) within a second patient, with Elon Musk, the company's CEO, saying the procedure is “working very well.”
Neuralink recently revealed that it chose to postpone the insertion of a second brain chip implant in a procedure that had been eagerly anticipated by the medical and tech communities.
The FDA has approved Elon Musk's Neuralink to implant its experimental brain chip technology in a second individual, following issues that arose with its first patient.
The rapidly expanding brain-computer interface (BCI) field is not only driving cutting-edge neuroscience but also fueling a competitive race for market dominance.
Physicists moving closer than ever to a 'Theory of Everything' and other science stories involving cosmology, robotics, and environmental mysteries are trending this week at The Debrief.
The U.S. Missile Defense Agency’s Long Range Discrimination Radar aims to serve as the backbone of the current Golden Dome initiative for protecting America.
Apple is reportedly working with brain-computer interface (BCI) company Synchron to develop technology that allows users to control their iPhones and other Apple devices using their minds.